Dosing Considerations for Non-Prescription Drugs in Infants and Children

References

• Assael B. M. Pharmacokinetics and Drug Distribution during Postnatal Development. Pharmac. Ther. 1982; 18: 159–197
   PubMed Web of Science ®Google Scholar
• Uges D., Schoostra R. Changed pharmacokinetics under the influence of age. Pharm. Weekblad 1987; 9: 50–55
   Google Scholar
• Agunod M., Yomaguchi N., Lopez R., Luhby A., Glass G. Correlative study of hydrochloric acid, pepsin and intrinsic factor secretion in newborns and infants. Amer. J. Dig. Dis. 1969; 14: 400–414
   PubMedGoogle Scholar
• Lebenthal L., Lee P., Heitlinger L. Impact of development of the gastrointestinal tract on infant feeding. J. Ped 1983; 102: 1–9
   PubMed Web of Science ®Google Scholar
• Milla P., Fenton T. Small intestinal motility patterns in the perinatal period. J. Ped. Gastroenterol. and Nut. 1983; 2: 5141–5144
   Google Scholar
• Nelson J., Shelton S., Kusmiesz H., Haltalin K. Absorption of Ampicillin and nalidixic acid by infants and children with acute shigellosis. Clin. Pharm. Ther. 1972; 13: 879–886
   PubMed Web of Science ®Google Scholar
• Stewart C., Hamtpton E. Effect of maturation on drug disposition in pediatric patients. Clin. Pharm. 1987; 6: 548–64
   PubMedGoogle Scholar
• Warner A. Drug use in the neonate: interrelationships of pharmacokinetics, toxity and biochemical maturity. Clin. Chem. 1986; 32: 721–727
   PubMed Web of Science ®Google Scholar
• Friis-Hansen B. Body water compartments in children: changes during growth and related changes in body composition. Pediatrics 1961; 28: 169–81
   PubMed Web of Science ®Google Scholar
• Bendayan R., Preper J., Stewart R., et al. Influence of age on serum protein binding of propranolol. Eur. J. Clin. Pharmacol. 1984; 26: 251–4
   PubMed Web of Science ®Google Scholar
• Carrier O., Pons G., et al. Maturation of caffeine metabolic pathways in infancy. Clin. Pharm. Ther. 1988; 44: 145–151
   PubMed Web of Science ®Google Scholar
• Levey G., Narinder N., Soda D., et al. Pharmacokinetics of acetaminophen in the human neonate; formulation of acetaminophen glucuronide and sulfate in relation to plasma bilirukin concentration and D-glucaric acid excretion. Pediatrics 1975; 55: 818–25
   PubMed Web of Science ®Google Scholar
• Schwartz, Feld G. L., Langford D. A simple estimate of glomeular filtration rate in full term infants during the first year of life. J. Ped. 1984; 104: 849–854
   PubMed Web of Science ®Google Scholar
• Marcadis M., Veerman M. OTC Dosages for Kids. American Druggist 1989; 200: 31–36
   Google Scholar
• Nykamp D., Meyahara R. OTC Counseling for the Pediatric Patient: An opportunity for pharmacist involvement. Amer. Pharm. 1990; NS30: 38–46
   PubMedGoogle Scholar
• Simons F. E., Luciuk G., Simons K. Pharmacokinetics and efficacy of chlorpheniramine in children. J. Allerg. Clin. Immunol. 1982; 69: 376–381
   PubMed Web of Science ®Google Scholar
• Rumore M. Clinical Pharmacokinetics of Chlorpheniramine. Drug Intelligence and Clinical Pharmacy 1984; 18: 701–7
   PubMedGoogle Scholar
• Thompson J. A., Bloedow D., Leffert F. Pharmacokinetics of intravenous chlorpheniramine in children. J. Pharm. Sci. 1981; 70: 1284–1286
   PubMed Web of Science ®Google Scholar
• AHFS Drug Information, G. McEvoy. Am. Soc. Hosp. Pharm., Bethesda, MD 1991; 4, 5, 9, 10
   Google Scholar
• Mandel E., Rockette H., Bluestone C., Paradise J., Nozza R. Efficacy of amoxicillin with and without decongestant-antihistamine for otitis media with effusion in children. NEJM 1987; 3016: 432–7
   Google Scholar
• Caantekin E., Mandel E., Bluestone C., Rockette H., Paradise J., Stool S., Fria T., Rogers K. Lack of efficacy of a decongestant-antihistamine combination for otitis media with effusion (“secretary” otitis media) in children. NEJM 1983; 308: 297–301
   PubMed Web of Science ®Google Scholar
• Aylward M., Maddock J., Davies, Protheroe D., Ludeman T. Dextromethorphan and codeine: comparison of plasma kinetics and antitussive effects. Eur. J. Respir. Dis. 1984; 65: 283–291
   PubMedGoogle Scholar
• Evans W., Relling, Petros W., Meyer W., Mirro J., Crom W. Dextromethorphan and caffeine as probes for simultaneous determination of debrisoquin-oxidation and N-acetylation phenotypes in children. Clin. Pharm. Ther. 1989; 45: 568–73
   PubMed Web of Science ®Google Scholar
• Woodworth J., Dennis S., Hinsvark O., Amsel L., Rotenbergy K. Bioavailability evaluation of a controlled-release dextromethorphan liquid. J. Clin. Pharmacol. 1987; 27: 244–138
   Google Scholar
• Shaul W., Wandell M., Robertson W. Dextromethorphan Toxicity: Reversal by Naloxone. Pedriatrics 1977; 59: 117–118
   PubMed Web of Science ®Google Scholar
• Lucarotti R., Colaizzi J., Barry H., Poust R. Enhanced Pseudoephedrine absorption by concurrent administration of aluminum hydroxide gel in humans. J. Pharm. Sci. 1972; 61: 903–905
   PubMed Web of Science ®Google Scholar
• Kuntzman R., Tsai K., Brand L., Mark L. The influence of urinary pH on the plasma half-life of pseudoephedrine in man and dog and a sensitive assay for its determination in human plasma. Clin. Pharm. Ther. 1971; 12: 62–67
   PubMed Web of Science ®Google Scholar
• Pentel P. Toxicity of Over-the-Counter Stimulants. JAMA 1984; 252: 1898–1903
   PubMed Web of Science ®Google Scholar
• Spielbergt S., Schulman J. A possible reaction to pseudoephedrine in a patient with phenylketonuria. J. Ped. 1977; 90: 1026
   PubMed Web of Science ®Google Scholar
• Porta M., Jick H., Habakangas J. Follow-up study of speudoephedrine users. Anals of Allergy 1986; 57: 340–342
   PubMed Web of Science ®Google Scholar
• Maynard W., Bruce R. GLC determination of guaniacol glyceryl ether in blood. J. Pharm. Sci. 1970; 59: 1346–1348
   PubMed Web of Science ®Google Scholar
• Naito S., Mizutani M., Osumi S., Umetsu K., Mikawa T. Biopharmaceutical studies on guiaiacol glycerol ether and related compounds. IV. Drug in blood and bile. J. Pharm. Sci. 1970; 59: 1742–1745
   PubMed Web of Science ®Google Scholar
• Naito S., Mizutani M., Osumi S. Biopharmaceutical studies on guaiacol glycerol ether and relatede compounds. V. J Pharm Sci 1972; 61: 1212–1215
   PubMed Web of Science ®Google Scholar
• Vaandenheuvel W., Smith J., Silker R. β-(2-methoxyphenoxyl) lactic acid, the major urinary metabolite of glyceryl guiacolate in man. J. Pharm. Sci. 1972; 61: 1997–1998
   PubMedGoogle Scholar